Researchers at USC have linked historical increases in human lifespan to reduced childhood exposure to infectious diseases like tuberculosis and malaria. Chronic inflammation from these early infections accelerated cardiovascular and other diseases, leading to increased longevity.
The National Science Foundation has funded six projects under its Ecology of Infectious Diseases program to understand the ecological and biological mechanisms behind relationships between human-induced environmental changes and infectious disease emergence. The research will focus on understanding disease transmission, unintended heal...
The Ellison Visiting Scholars Program brings African scientists to the Marine Biological Laboratory (MBL) to study infectious diseases, including the African trypanosome that causes human sleeping sickness. The program aims to develop strategies for combating these diseases with the help of MBL's cutting-edge facilities and expertise.
The project aims to advance scientific research against bioterrorism agents and emerging infectious diseases through a unified proteomics data management system. The system will store proteomics information from six Proteomics Research Centers, providing free public access and enabling direct queries.
The Virginia Tech National Bioinformatics Resource Center will focus on Brucella, Caliciviruses, hepatitis A, Rabiesvirus, and Coxiella burnetii/Rickettsias. The center will enable researchers to access, analyze, and study molecular data for these infectious diseases.
Researchers found that climatic factors are the most important determinant of human pathogen distribution, contradicting conventional assumptions about disease control. Understanding ecological links between disease and environment could inform effective preventive strategies.
The partnership aims to enhance Peruvian research capacity in biomedical research, including lab-based and fieldwork. The project will cover research ethics, health economics, and train local researchers, physicians, biologists, nurses, and students.
Chronic diseases are the largest cause of death worldwide, with a projected increase in global prevalence over the next two decades. Key risk factors include tobacco use, unhealthful diets, and lack of physical activity, with most cases occurring in developing countries.
Researchers found that cross-priming, a key mechanism in T-cell activation, is directly correlated with the levels of whole proteins expressed by virus-infected cells. This new information could lead to the development of vaccines effective against infectious diseases such as HIV/AIDS and malaria.
The Emory research team will model disease outbreaks in hypothetical American communities to find the best methods of controlling epidemics. They will also investigate the interaction of microorganisms with the immune system and its relation to disease spread.
Researchers found that simple public health measures can contain highly transmissible diseases like SARS and smallpox. In contrast, moderately transmissible viruses like HIV and pandemic influenza require more complex control measures due to early symptom onset.
The MIDAS (Mathematical Information Domain for Assessment of Substantial Threats) project will create mathematical models to study infectious disease epidemics and community responses. The project, funded by the NIH, will provide user-friendly computer modeling tools for predicting and responding to bioterror threats.
Weinstein is recognized for his landmark articles on laboratory detection of bacterial and fungal infections, as well as his contributions to clinical decision-making in infectious disease medicine. He has also served on editorial boards of several journals and holds prestigious fellowships.
A study suggests that regular doses of cranberry juice or tablets can reduce the risk of female urinary tract infections (UTIs) by up to 50% in sexually active adult women. Cranberry juice's effectiveness in treating existing UTI cases is still unknown, but it offers a potential natural alternative to antibiotics.
A recent USGS review of scientific literature reveals increased reports of disease outbreaks in turtles, corals, mollusks, mammals, and urchins since 1970. However, no significant trends were detected for seagrasses, decapods, or sharks/rays, with even a decrease in disease reports among fish.
The Howard Hughes Medical Institute is providing 80 scientists with five-year grants to conduct basic biomedical research in their own countries. This initiative aims to combat emerging and established infectious diseases, such as malaria and tuberculosis, and support the development of scientific capacity in regions hit by brain drain.
A team of scientists has successfully tested a new smallpox vaccine that shows promise as an alternative to the existing Dryvax vaccine. The MVA vaccine was found to elicit equivalent or higher immune responses in nonhuman primates, providing protection against monkeypox.
Chlorine dioxide-infused gloves can destroy various microorganisms, including E. coli and salmonella, reducing transmission risks in medical and food industries. The technology has potential applications beyond gloves and hands, including preventing infections in vulnerable patients.
US state and territorial health departments have limited online resources for reporting infectious diseases, a study found. Updating these sites to provide complete, accessible disease reporting information could strengthen partnerships between clinicians and public health officials and improve disease surveillance.
The study highlights the need for greater support and educational intervention during infectious disease outbreaks. Front-line health care workers are at real danger of becoming infected, as seen in SARS cases where 20% of infected individuals were healthcare workers.
The Netherlands has established two new research centers, NIVAREC and PRIOR, to develop and produce flu vaccines and tackle poverty-related infectious diseases. The centers aim to strengthen cooperation between researchers from different institutes and foster knowledge infrastructure in developing countries.
Researchers at USAMRIID successfully detected variola virus in a 50-year-old tissue sample using integrated diagnostic methods. The study demonstrates the capabilities of modern molecular diagnostics in identifying biological agents, which is crucial for national defense and infectious disease research.
A new study has shown that vaccinia transfer after smallpox immunization is extremely low if proper precautions are taken. The risk of transmission can be greatly reduced by keeping the vaccine site bandaged and practicing thorough hand-washing.
Researchers developed a framework to account for mutations in models assessing emerging infectious disease emergence, highlighting the potential for long transmission chains and disease adaptation. The model suggests that even low reproductive numbers can lead to dramatic outbreaks as new strains evolve.
Researchers at USAMRIID have developed Ebola virus-like particles (VLPs) that induce both cell-mediated and humoral immunity in mice, providing 100% protection against lethal challenge. The VLPs, resembling infectious viral particles without genetic material, offer a promising vaccine platform for Ebola and other viruses.
The first human trial of a DNA Ebola vaccine opened at the NIH Clinical Center in Bethesda. Twenty-seven volunteers will receive either the investigational vaccine or a placebo injection over two months and be followed for one year.
A study by Duke University researchers found that a fungus's ability to breach the immune system is linked to an enzyme called flavohemoglobin. The team discovered that this enzyme plays a crucial role in defending against nitric oxide produced by the immune system, and that disabling it can significantly reduce fungal virulence.
The new program combines counseling and education efforts with medical therapy to reduce HIV levels in patients. The initiative aims to assess the impact of integrating prevention services into primary care on HIV risk behaviors and outcomes.
A recent investigation found that a Texas salvage store was the source of a foodborne botulism outbreak. Food safety experts advise customers to inspect packaging for signs of decay and spoilage, as well as to maintain standards of health when shopping at any facility.
Dawn Wooley, a WSU researcher, is working with a team of universities to develop diagnostic tools, therapeutics, and vaccines for deadly agents and viruses. The Midwest Center of Excellence aims to create solutions to counter biological threats, with a focus on airborne agents.
A Dartmouth study has found that RNA molecules can catalyze the transformation of normal prion proteins into disease-causing counterparts, potentially leading to early detection and treatment of prion diseases. The discovery opens new avenues for exploration in diagnosis and treatment of neurodegenerative disorders.
The NIAID initiative addresses primary immune deficiency diseases by focusing research priorities and uniting established researchers with new investigators. A cell line repository and Web-based patient registry will also be created to advance understanding of these lesser-known diseases.
Under the contract, TIGR will sequence dozens of genomes per year to provide data for vaccine and antimicrobial drug development projects. The institute's affiliated facility has already conducted sequencing for over 50 organisms, including microbes that cause various diseases.
The NIH has awarded $51 million to fund the Autoimmunity Centers of Excellence program, which aims to develop new immune-based therapies for autoimmune diseases. This expansion will enhance interactions between scientists and clinicians to accelerate translation of research findings into medical applications.
The Virginia Bioinformatics Institute is at the forefront of a new regional center of excellence for biodefense and infectious disease research. This initiative aims to combat infectious diseases, including potential bioterrorism threats, by leveraging genomics, bioinformatics, and supercomputing capabilities.
The National Institute of Allergy and Infectious Diseases is launching a new program to support interdisciplinary research on infectious diseases, with eight regional centers expected to be established. The program aims to develop new therapies, vaccines, diagnostics, and tools to combat bioterrorism and emerging diseases.
A mystery illness in western Montana was solved by researchers identifying the cause as Borrelia hermsii, a spiral-shaped bacterium. The disease is curable with antibiotics and can cause recurrent febrile illnesses, highlighting the potential for emerging diseases in previously unrecognised areas.
A live but weakened virus is being tested as a potential West Nile virus vaccine, with promising results showing high levels of protective antibodies in monkeys. The vaccine has been shown to be effective in preventing the disease-causing virus while triggering a strong immune response.
Scientists at NIAID and USAMRIID developed a prime-boost vaccine strategy that protects monkeys from Ebola infection. The boost alone shows promise in offering quick but weaker immune response.
Scientists at the University of Toronto have made a breakthrough in understanding how to diagnose, treat, and potentially prevent infectious prion diseases like mad cow disease. By identifying specific amino acid sequences on abnormal prions, they were able to develop antibodies that can recognize and attack these rogue proteins.
Bacteriophage, or phage, previously thought not to be infectious to humans, may be a new target for fighting certain bacteria that produce toxins. Scientists found that phage can transfer toxins and genes between bacteria, transforming harmless microbes into virulent bugs.
Researchers from The Institute of Genomic Research sequenced B. anthracis genome to improve vaccine design and drug development. Despite similarities with closely related bacteria, the study found unique genes giving B. anthracis its ability to thrive on protein-rich matter.
Scientific studies have found no link between vaccines and chronic diseases such as asthma and food allergies. Reducing vaccination rates can lead to increased rates of preventable infectious diseases, according to the article co-authored by Dr. Paul Offit.
The HHS research plan aims to improve understanding of autoimmune diseases through genetic and environmental factor studies. The plan also calls for developing new treatments and diagnostics, as well as public education campaigns.
The Jordan Report 20th Anniversary outlines significant advancements in vaccine research for diseases like HIV/AIDS, tuberculosis, malaria, and bioterrorism threats. The report emphasizes the importance of vaccines in preventing illness and death from infectious diseases.
Researchers have developed a highly sensitive automated test for detecting prions in cattle, sheep, deer, and elk, significantly improving the accuracy and speed of detection. The test, an immunological probe, uses novel antibodies to reveal and measure infectious abnormal prion protein.
Otitis media is a common childhood infection with rising antibiotic resistance; the Lancet Infectious Diseases review calls for targeted larval mosquito strategies. A systematic review of over 5000 women also finds that cheap spermicide gels are ineffective in reducing HIV-1 and other STIs.
The Lancet Oncology and Infectious Diseases examine the effectiveness of cancer prevention strategies, including chemoprevention and lifestyle changes. Researchers also explore the impact of HIV treatment on reducing epidemics and developing vaccines against the virus.
A recent study by Emory University Health Sciences Center found that lower levels of social capital are associated with higher rates of sexually transmitted diseases. The research, which analyzed data from 48 US states, discovered that social capital is a significant predictor of infectious diseases including AIDS and STDs.
A multi-center trial shows that new drug combinations, including two protease inhibitors, can significantly lower virus counts in patients with moderately advanced immunodeficiency. The study found that 31% of patients could achieve detectable viral loads with regimens containing four or five new drugs.
A study by Kevin Lafferty and Leah Gerber found that non-otter diseases, such as parasitic worms and toxoplasmosis, are contributing to the decline of California sea otter populations. Improving waste disposal and reducing human exposure to these diseases may help protect the otters.
Researchers have identified genes unique to group A Streptococcus bacteria that cause acute rheumatic fever, a leading cause of childhood heart disease. The study also reveals that genetic material from different strains can be swapped, enabling the spread of the disease.
The University of Washington has established a new center to combat deadly microbial pathogens, which threaten human health worldwide. Researchers will focus on developing treatments and vaccines for diseases caused by Pseudomonas aeruginosa, pathogenic protozoa, and other infectious agents.
Researchers found that high-dose, short-term chlorambucil treatment resulted in sustained inflammation reduction for 77% of patients with severe, non-infectious uveitis. The study's findings suggest that chlorambucil may become a preferred treatment option for these patients.
The collaboration will focus on understanding infectious disease pathogens, host interactions, and environmental factors. Researchers will develop technologies for rapid detection, identification, and remediation of pathogens.
Researchers at Dana-Farber Cancer Institute have developed a method for detecting unknown microorganisms in human tissue, leveraging DNA sequencing data. The technique, called computational subtraction, has shown promise in identifying novel infectious agents in mysterious chronic diseases.
A study led by the NIH/NIAID identified Norwalk-like viruses as the primary cause of gastroenteritis outbreaks in Maryland nursing homes. The research revealed six distinct genetic clusters among these viruses, with a predominant GII 'Bristol-like' virus strain detected in 14 of the 20 outbreaks.
A global white paper on bacterial resistance in respiratory tract infections calls for concerted international action to tackle the growing threat of antibiotic-resistant bacteria. The initiative aims to implement robust surveillance, education, and patient involvement to control resistance.
The US government is investing in bioterrorism research through seven new initiatives, aiming to develop vaccines and treatments for diseases like anthrax and smallpox. The initiatives will also support basic research and partnerships between academia, industry, and government.
A Yale gastroenterologist has received a $1 million grant to study infectious diseases in developing countries. The grant will support collaborative research on improved oral rehydration solutions for diarrheal diseases, which are common causes of death among children worldwide.